Casacol Expectorant SyrupMethoxyphenamine hydrochloride 20 mg/5 ml Guaiphenesin 100 mg/5 ml Sodium Citrate 200 mg/5 ml Ireland - English - HPRA (Health Products Regulatory Authority)

casacol expectorant syrupmethoxyphenamine hydrochloride 20 mg/5 ml guaiphenesin 100 mg/5 ml sodium citrate 200 mg/5 ml

phoenix labs - methoxyphenamine hydrochloride; sodium citrate; guaiphenesin - syrup - 20 mg/5ml/100 mg/5ml/200 mg/5ml - expectorants; combinations

RAPID-ACID-NEUTRALIZER FOR HORSES AND GREYHOUNDS Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rapid-acid-neutralizer for horses and greyhounds

sykes vet (international) pty. ltd. - citric acid; potassium citrate; sodium citrate - oral solution/suspension - citric acid acid-general active 40000.0 mg/l; potassium citrate mineral-potassium active 80000.0 mg/l; sodium citrate mineral-sodium-salt active 280000.0 mg/l - genitourinary system - dog - greyhound | horse | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at stud | - acidosis | body acid neutraliser | dehydration | diuretic, acidifier or alkaliniser | acidification | acidifier | acidifying | acidosis | alkaliniser | bronchodilator | cardiac stimulant | dehydration | diuresis | diuretic | feline struvite urolithias | fluid retention | hepatotoxic drugs | kidney antiseptic | liver damage | methionine treatment | oedema | parturient udder oedema | retention of fluid | saluresis | stimulant - cardiac | struvite urolithiasis | tonus-improving | tying-up | udder oedema | urinary alkalizer | urinary antiseptic | urinary buffer | urinary calculi | urine | urolithiasis | uterine pessaries

AS 3- dextrose monohydrate, sodium citrate, sodium chloride, sodium phosphate, monobasic, monohydrate, citric acid monohydrate a United States - English - NLM (National Library of Medicine)

as 3- dextrose monohydrate, sodium citrate, sodium chloride, sodium phosphate, monobasic, monohydrate, citric acid monohydrate a

terumo bct ltd - dextrose monohydrate (unii: lx22yl083g) (anhydrous dextrose - unii:5sl0g7r0ok), sodium citrate, unspecified form (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), sodium chloride (unii: 451w47iq8x) (chloride ion - unii:q32zn48698), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr), citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), adenine (unii: jac85a2161) (adenine - unii:jac85a2161) - dextrose monohydrate 1.1 g in 100 ml - intended for use only with trima and trima accel automated red blood cell apheresis devices and atreus whole blood processing system. see operator's manuals for additional information and complete usage instructions. sterile. non-pyrogenic. do not use unless the solution is clear and the container is intact. rx only. single use container.

Fenwal Plasmapheresis Blood-Pack Unit with 4% Sodium Citrate Dihydrate Anticoagulant Solution Namibia - English - Namibia Medicines Regulatory Council

fenwal plasmapheresis blood-pack unit with 4% sodium citrate dihydrate anticoagulant solution

adcock-ingram critical care - sodium citrate dihydrate 4 g - blood bag - sodium citrate dihydrate 4 g/100ml

Enerlyte Oral Rehydration Salts (Natural) Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

enerlyte oral rehydration salts (natural)

duopharma marketing sdn. bhd. - sodium chloride; trisodium citrate; potassium chloride; glucose, anhydrous -

BENNATUSS EXPECTORANT Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

bennatuss expectorant

hoe pharmaceuticals sdn. bhd. - sodium citrate/trisodium citrate; diphenhydramine hydrochloride; ammonium chloride -

Anticoagulant Sodium Citrate New Zealand - English - Medsafe (Medicines Safety Authority)

anticoagulant sodium citrate

baxter healthcare ltd - sodium citrate dihydrate 4% - solution for infusion - 4 % - active: sodium citrate dihydrate 4%

SODIUM VALPROATE WOCKHARDT sodium valproate 1000 mg/10 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 1000 mg/10 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 1000 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

SODIUM VALPROATE WOCKHARDT sodium valproate 400 mg/4 mL solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

sodium valproate wockhardt sodium valproate 400 mg/4 ml solution for injection ampoule

wockhardt bio pty ltd - sodium valproate, quantity: 400 mg - injection, solution - excipient ingredients: dibasic sodium phosphate dodecahydrate; monobasic sodium phosphate dihydrate; phosphoric acid; sodium hydroxide; water for injections - sodium valproate wockhardt is used for the treatment of patients with epilepsy or mania, who would normally be maintained on oral sodium valproate, and for whom oral therapy is temporarily not possible.

TRICITRATES- potassium citrate, sodium citrate, and citric acid monohydrate solution United States - English - NLM (National Library of Medicine)

tricitrates- potassium citrate, sodium citrate, and citric acid monohydrate solution

atlantic biologicals corp. - potassium citrate (unii: ee90oni6ff) (anhydrous citric acid - unii:xf417d3psl), sodium citrate (unii: 1q73q2julr) (anhydrous citric acid - unii:xf417d3psl), citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl) - tricitrates sf oral solution is an effective alkalinizing agent useful in those conditions where long-term maintenance of an alkaline urine is desirable, such as in patients with uric acid and cystine calculi of the urinary tract. in addition, it is a valuable adjuvant when administered with uricosuric agents in gout therapy, since urates tend to crystallize out of an acid urine. it is also effective in correcting the acidosis of certain renal tubular disorders. this product is highly concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urine ph around the clock, usually without the necessity of a 2 a.m. dose. this product alkalinizes the urine without producing a systemic alkalosis in recommended dosage. it is highly palatable, pleasant tasting, and tolerable, even when administered for long periods. potassium citrate and sodium citrate do not neutralize the gastric juice or disturb digestion. severe renal impairment with oliguria or azotemia, untreated addi